<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:department>Cal Unit (Medical Faculty)</gtr:department><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/33315F93-BB00-491D-A280-E191361BD24E"><gtr:id>33315F93-BB00-491D-A280-E191361BD24E</gtr:id><gtr:firstName>Cosimo</gtr:firstName><gtr:surname>De Bari</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/57F95E65-24B4-480E-A584-47B287602441"><gtr:id>57F95E65-24B4-480E-A584-47B287602441</gtr:id><gtr:firstName>Henning</gtr:firstName><gtr:surname>Wackerhage</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E2431A12-51E3-4F82-B76A-C6822C5869AF"><gtr:id>E2431A12-51E3-4F82-B76A-C6822C5869AF</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>Steven</gtr:otherNames><gtr:surname>Zammit</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1100193"><gtr:id>4D7DE202-07C6-4E83-BBF1-BC0B0D74DB7C</gtr:id><gtr:title>Yap: a novel regulator of satellite cell fate with regenerative medicine potential</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1100193</gtr:grantReference><gtr:abstractText>Stem cells are required to maintain and regenerate our organs. Stem cells are also a treatment option and could potentially be used to replace dead insulin-secreting cells in the pancreas of patients with diabetes. Another strategy is to develop drugs for example to stimulate the production of additional stem cells by the body itself. This could potentially be used to increase the number of stem cells in aged human muscle, where it is reduced roughly by half. The aim of the proposed project is to investigate for the first time a protein termed Yap in satellite cells which are the stem cells of our muscles. We hypothesize that Yap is important for controlling the number of muscle stem cells and their repair activity. To test our hypothesis we will either remove or overactivate Yap in muscle stem cells and then investigate how this affects the numbers and repair activity of muscle stem cells. We then aim to identify the parts on our chromosomes to which Yap binds to in order to investigate how Yap exerts its function in muscle stem cells. Taken together, these experiments will inform us whether Yap is a suitable drug target to modulate the numbers and repair activity of muscle stem cells. If it was then Yap-targetting treatments could be used in the management for example in regulating the behaviour of stem cells in patients with muscular dystrophy and in the elderly.</gtr:abstractText><gtr:technicalSummary>Satellite cells are somatic skeletal muscle stem cells. Recent experiments demonstrate that satellite cell grafts can be used to improve function in dystrophic muscles and ameliorate muscle ageing in rodents. Thus satellite cell based therapies are now a much more realistic strategy for the treatment of human disease and ageing than several years ago. Satellite cells could potentially also be targeted in situ for example to increase the decreased satellite cell numbers in sarcopenic muscle. Our preliminary data suggest that the Hippo pathway and its core member Yap are expressed in muscle cells including satellite cells. Our functional studies so far suggest that Yap can potentially be targeted to expand satellite cells or to manipulate asymmetric cell division. The aim of the proposed project is to study the function of Yap in satellite cells in vivo. To test whether Yap is required for satellite cell identity, activation and proliferation, we wish to breed a transgenic mouse with a switch that will allow us to knock out Yap selectively in satellite cells. We then wish to study whether postnatal growth, muscle regeneration after injury and muscle hypertrophy are affected as satellite cells play a key role in these processes. Next we plan to transplant transgenic satellite cells into mdx-nude recipient mice and then induce the overexpression of constitutively active hYAP1 S127A in the satellite cell grafts. This gold standard experiment of satellite cell biology will inform us whether Yap can be targeted to activate and/or expand satellite cells and whether Yap affects asymmetric cell division and thus the numbers of satellite cells that go on to differentiate or self-renew. We will also see how this affects the expression of dystrophin in the dystrophic recipients. Finally, we plan to use a method known as ChIP-Seq (i.e. chromatin immunoprecipitation followed by next generation sequencing) to identify binding sequence motifs to which Yap co-activated transcription factors bind in satellite cells and the genes that are directly regulated by Yap. This last experiment will give us insight into how Yap achieves its effects. This is not only important to understand the function of Yap in satellite cells but potentially also in other somatic stem cells, where Yap has already been identified as a key regulator. Taken together, these experiments will inform us about the function of Yap in satellite cells in vivo and about potential clinical applications.</gtr:technicalSummary><gtr:fund><gtr:end>2015-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>508767</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Prof Peter Zammit</gtr:description><gtr:id>AEB1BD30-5F8E-46D1-9D0B-6BC8F52DC7B4</gtr:id><gtr:impact>MRC grant 2010
Judson et al. Journal of Cell Sci 2012</gtr:impact><gtr:outcomeId>oVenHUWE8KR-1</gtr:outcomeId><gtr:partnerContribution>Prof. Pete Zammit has helped us to learn the satellite cell technique and was co-applicant on our MRC grant</gtr:partnerContribution><gtr:piContribution>We have started research on the Hippo pathway in skeletal muscle and have developed Hippo reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Dr. Fernando Camargo</gtr:description><gtr:id>077848F6-09DF-4954-9630-3C10A3C36526</gtr:id><gtr:impact>Judson et al. J Cell Sci 2012</gtr:impact><gtr:outcomeId>XcLJbr8wkBs-1</gtr:outcomeId><gtr:partnerContribution>Dr. Fernando Camargo has contributed microarray data where the effect of Yap over expression in myoblasts was studied</gtr:partnerContribution><gtr:piContribution>We have studied the activation and function of Yap in satellite cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MyoBlog</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2E5F28BE-01ED-4E5F-B41D-91F0963032C6</gtr:id><gtr:impact>We have started a science blog termed 'myoblog' to present our work and related research to a wider audience. 



After 2 months the blog already has 1440 hits (6.11.2013).</gtr:impact><gtr:outcomeId>eV7aYiRjkAS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://molecularexercisephysiology.blogspot.co.uk/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Why do muscles age and what can we do about it?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4D7875AF-6611-4ED4-B829-335CB82DC9EF</gtr:id><gtr:impact>This was a talk to a group of coaches, elderly etc who are interested in building and maintaining muscle mass and function. We plan an Open day for 2014.

I have been asked to give a similar talk again this year.</gtr:impact><gtr:outcomeId>b7HjdFbE4in</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>First Aberdeen Myology Meeting, 25.4.2014</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>12E19281-869E-43BC-8561-50BADF170FFF</gtr:id><gtr:impact>We organised an Open Day for our current MRC-funded project (G1100193). For this we invited Profs. Zammit (King's College; satellite cells, dystrophy), Harridge (King's College; Master's athletes, muscle ageing) and Rennie (Emeritus; sarcopenia and protein synthesis) and HW (muscle cancer) gave a talk as well. All speakers gave presentation where the first half of the talk was suitable for the general public and the second talk was more in-depth research which worked very well. We have produced a blog entry. 


The Aberdeen Myology Meeting was attended by colleagues from Scottish Institutions, colleagues at Aberdeen, students and the general public. The key impact was to showcase our research and to discuss various topics in muscle research including muscle stem cells, muscle ageing, Masters's athletes and sarcopenia. The feedback was very good as the general introductions allowed participants who had little knowledge of muscle research to follow the presentations.</gtr:impact><gtr:outcomeId>54130ba9be43e7.61688642</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://molecularexercisephysiology.blogspot.co.uk/2014/05/first-aberdeen-myology-meeting-2542014.html</gtr:url></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release for our Cancer Cell paper that the Hippo effector Yap causes embryonal rhabdomyosarcoma</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E2B9C9C8-FCA9-4E04-AB92-7566EB8CD2C3</gtr:id><gtr:impact>We had several e-mails from patients and relatives often saying that they were delighted that this research was carried out.

Newspaper and online articles, radio interviews and one TV report: 
http://news.stv.tv/north/284633-cause-of-rare-childhood-cancer-found-in-research-breakthrough/</gtr:impact><gtr:outcomeId>54130dfb34f6c4.75258217</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.abdn.ac.uk/news/6554/</gtr:url></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>34720D9B-546B-4826-A926-CECEBE875B5E</gtr:id><gtr:title>The Hippo signal transduction network for exercise physiologists.</gtr:title><gtr:parentPublicationTitle>Journal of applied physiology (Bethesda, Md. : 1985)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/126f2d1e043f261defbf31737a8fc8df"><gtr:id>126f2d1e043f261defbf31737a8fc8df</gtr:id><gtr:otherNames>Gabriel BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0161-7567</gtr:issn><gtr:outcomeId>56e14609c40ce1.86438113</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F550422-6EBF-4B95-87EB-87C10E6F0FCE</gtr:id><gtr:title>The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42548a444308561da213fa98d07ae15d"><gtr:id>42548a444308561da213fa98d07ae15d</gtr:id><gtr:otherNames>Tremblay AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>54130916ebcf05.37695084</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6873A256-C945-4962-9FE2-12CE8DE71FE9</gtr:id><gtr:title>Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe6fb30202b8d9e33b80e36016bd63d"><gtr:id>0fe6fb30202b8d9e33b80e36016bd63d</gtr:id><gtr:otherNames>Sun C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>5aa96419710d01.28316955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF7F131E-4313-4AEA-B193-4D2F26E1CD7C</gtr:id><gtr:title>Yes-associated protein (YAP) is a negative regulator of chondrogenesis in mesenchymal stem cells.</gtr:title><gtr:parentPublicationTitle>Arthritis research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4294ca5dbc3027b5e6b6d457c959e82"><gtr:id>e4294ca5dbc3027b5e6b6d457c959e82</gtr:id><gtr:otherNames>Karystinou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1478-6354</gtr:issn><gtr:outcomeId>56e1460a28a2b6.58560181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC3D9AE7-464A-417E-B5DC-61A0D11C9355</gtr:id><gtr:title>Isolation, culture and immunostaining of skeletal muscle fibres to study myogenic progression in satellite cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc8ea94ff97f9dafdbcaba6d4c16059d"><gtr:id>bc8ea94ff97f9dafdbcaba6d4c16059d</gtr:id><gtr:otherNames>Moyle LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>585d5a07977ec5.01250323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C2EB13E-9404-495E-AA60-1DF3873E6036</gtr:id><gtr:title>ErbB3 binding protein-1 (Ebp1) controls proliferation and myogenic differentiation of muscle stem cells.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2eade06a0a1988cfcb2e1b784686eeb"><gtr:id>f2eade06a0a1988cfcb2e1b784686eeb</gtr:id><gtr:otherNames>Figeac N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>doi_55f985985aed6aaa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36CEA12C-30AD-4858-A071-0AE451BFF22F</gtr:id><gtr:title>The Hippo pathway member Yap plays a key role in influencing fate decisions in muscle satellite cells.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/042ea160b95d431df1347cc614e9b69e"><gtr:id>042ea160b95d431df1347cc614e9b69e</gtr:id><gtr:otherNames>Judson RN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_13788_28_23038772</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D8FF897-320F-4E58-9937-E90114F11761</gtr:id><gtr:title>The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed7e3be9151c4ad116fca00118ae80e4"><gtr:id>ed7e3be9151c4ad116fca00118ae80e4</gtr:id><gtr:otherNames>Mohamed A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>58c655123d4cf6.71914533</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D17FC80-EF0A-4CC1-8130-2BB81A32EFF9</gtr:id><gtr:title>The Hippo signal transduction network in skeletal and cardiac muscle.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b002bf948539435170d1ad1aab473561"><gtr:id>b002bf948539435170d1ad1aab473561</gtr:id><gtr:otherNames>Wackerhage H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>54130916669911.71245316</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93AB14B7-20AC-41EC-9CAE-E04B92D8D490</gtr:id><gtr:title>The Hippo signal transduction pathway in soft tissue sarcomas.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0e378d45ebf4fa3aa155999267881a8"><gtr:id>f0e378d45ebf4fa3aa155999267881a8</gtr:id><gtr:otherNames>Mohamed AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>56e1460a0ae8c1.64805965</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDAE03C1-1BE6-4261-BC22-05946C1F018A</gtr:id><gtr:title>Constitutive expression of Yes-associated protein (Yap) in adult skeletal muscle fibres induces muscle atrophy and myopathy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/042ea160b95d431df1347cc614e9b69e"><gtr:id>042ea160b95d431df1347cc614e9b69e</gtr:id><gtr:otherNames>Judson RN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_13788_ne_0059622</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1100193</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>